This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should Altria Stock Be in Your Portfolio Ahead of Q1 Earnings?
by Zacks Equity Research
MO's Q1 results are likely to reflect macroeconomic pressures and declining cigarette volumes, though growth in smoke--free products may help.
Altria Trading at a Discount: Should You Buy, Sell or Hold the Stock?
by Ansuiya Mohta
MO's low valuation reflects structural challenges, making it a risky bet amid declining volumes, regulatory pressure, and rising illicit competition.
Zacks Industry Outlook Equity Philip Morris, Altria and Turning Point Brands
by Zacks Equity Research
Philip Morris, Altria and Turning Point Brands have been highlighted in this Industry Outlook article.
3 Tobacco Stocks Worth Watching on Robust Industry Trends
by Ansuiya Mohta
Tobacco companies like PM, MO and TPB are investing heavily in smoke-free products to align with health trends and regulatory shifts.
MO Stock Up 5% in a Month: Lock in Gains or Hold for More Upside?
by Ansuiya Mohta
Altria's focus on innovation and its transition to reduced-risk products provide an upside, although risks from illicit market growth remain.
Turning Point Brands (TPB) Q4 Earnings Lag Estimates
by Zacks Equity Research
Turning Point Brands (TPB) delivered earnings and revenue surprises of -7.02% and 0.23%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Turning Point Brands (TPB) Q4 Earnings Expected to Decline
by Zacks Equity Research
Turning Point Brands (TPB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is ThredUp (TDUP) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how ThredUp (TDUP) and Turning Point Brands (TPB) have performed compared to their sector so far this year.
Is Altria Stock a Buy, Sell or Hold at a P/E Multiple of 10.29X?
by Ansuiya Mohta
MO presents an attractive valuation with growth potential. But investors should be cautious of challenges like increasing competition and declining cigarette shipments.
Philip Morris (PM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 2.65% and 3.67%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Altria (MO) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 1.57% and 1.12%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
MO Stock Falls 4% in a Month: Is Now the Right Time to Buy?
by Ansuiya Mohta
MO's strong position in the smoke-free market, cost-savings and favorable earnings outlook position it as an attractive stock with growth potential.
Altria Stock Trading Cheaper Than Industry: What's the Next Best Move?
by Ansuiya Mohta
MO shows resilience through strategic partnerships and pricing power amid challenges from illicit products and declining cigarette volumes.
Altria Stock Reaches 52-Week High: Time to Capitalize or Wait?
by Ansuiya Mohta
Altria's smoke-free strategy and pricing power make it a compelling option for value-focused investors despite challenges from declining cigarette volumes.
PM Stock Rallies 30% in 6 Months: What Should Investors Do Next?
by Ansuiya Mohta
Philip Morris is driving strong growth through its smoke-free transformation, supported by innovation, global expansion, pricing power, and disciplined cost management.
Altria (MO) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 1.47% and 1.05%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Altria Stock a Buy, Sell or Hold at a P/S Multiple of 4.2X?
by Vrishali Bagree
Altria struggles with challenges in the Smokeable Products unit, driven by economic pressures on consumers and the rise of illegal e-vapor alternatives.
Should Altria Stock be in Your Portfolio Ahead of Q3 Earnings?
by Vrishali Bagree
Altria faces challenges from macroeconomic pressures and a surge in illegal e-vapor products, though smoke-free offerings provide some support.
Philip Morris (PM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 4.37% and 3.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Altria Stock Trading Above 200 & 50-Day SMA: Is it a Good Time to Buy?
by Vrishali Bagree
Altria's strong brand equity and growing presence in the smoke-free product space provide a solid foundation for resilience in a competitive landscape.
Zacks Industry Outlook Highlights Philip Morris, Altria, Turning Point Brands and 22nd Century
by Zacks Equity Research
Philip Morris, Altria, Turning Point Brands and 22nd Century have been highlighted in this Industry Outlook article.
4 Tobacco Stocks Worth Watching Despite Industry Concerns
by Vrishali Bagree
The Zacks Tobacco industry players battle concerns surrounding soft cigarette volumes and high input costs, while pricing power and smoke-free products aid. Philip Morris (PM), Altria Group (MO), Turning Point (TPB) and 22nd Century Group (XXII) look well-placed.
Are Consumer Staples Stocks Lagging Vita Coco Company (COCO) This Year?
by Zacks Equity Research
Here is how Vita Coco Company, Inc. (COCO) and Turning Point Brands (TPB) have performed compared to their sector so far this year.
All You Need to Know About Turning Point Brands (TPB) Rating Upgrade to Strong Buy
by Zacks Equity Research
Turning Point Brands (TPB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks Industry Outlook Highlights Philip Morris International, Altria Group and Turning Point Brands
by Zacks Equity Research
Philip Morris International, Altria Group and Turning Point Brands have been highlighted in this Industry Outlook article.